Skip to main content

View full-text article in PMC

. 2011 Oct 14;17(38):4289–4297. doi: 10.3748/wjg.v17.i38.4289

Table 5.

Apoptotic rate in gastric cancer cells 48 h after treatment with rAd-p53, oxaliplatin or rAd-p53 plus oxaliplatin

Treatment	Gastric cancer cell line
	rAd-p53 (vp/mL)	OXA (μg/mL)	SGC-7901	BGC-823	HGC-27
OXA	0	3.2	33.52 ± 1.6^e ^a	23.28 ± 1.35^e ^a	18.72 ± 1.61^e ^a
rAd-p53	5 × 10⁶	0	7.89 ± 1.13^c ^a	6.51 ± 0.97^c ^a	4.07 ± 0.83^c ^a
	5 × 10⁷	0	12.47 ± 1.43^c ^a	8.78 ± 1.34^c ^a	6.43 ± 0.79^c ^a
	5 × 10⁸	0	21.84 ± 1.05^c ^a	14.24 ± 0.89^c ^a	11.72 ± 1.12^c ^a
	5 × 10⁹	0	36.73 ± 1.03^c ^a	28.64 ± 1.75^c ^a	21.82 ± 1.81^c ^a
rAd-p53 + OXA	5 × 10⁶	3.2	42.38 ± 1.51^e ^c ^a	35.72 ± 1.13^e ^c ^a	28.84 ± 1.21^e ^c ^a
	5 × 10⁷	3.2	54.84 ± 1.26^e ^c ^a	48.63 ± 1.62^e ^c ^a	34.51 ± 1.47^e ^c ^a
	5 × 10⁸	3.2	58.41 ± 1.13^e ^c ^a	51.71 ± 1.41^e ^c ^a	38.5 ± 1.16^e ^c ^a
	5 × 10⁹	3.2	63.91 ± 1.23^e ^c ^a	55.73 ± 1.35^e ^c ^a	42.92 ± 1.33^e ^c ^a
Control	0	0	4.67 ± 1.32	1.74 ± 0.67	1.15 ± 0.58

^a

P < 0.05 vs control;

^c

P < 0.05, rAd-p53 vs rAd-p53 + oxaliplatin (OXA) with the same dose of rAd-p53;

^e

P < 0.05, OXA vs rAd-p53 + OXA at the same dose of OXA.